When does Jardiance’s patent expire?
Jardiance (empagliflozin) is protected by multiple patents covering the drug substance, formulations, and related methods. Patent “expiration” for a brand typically depends on which specific patent is being asked about, and whether any patent term adjustments, exclusivity extensions, or pending litigation affect effective market protection.
DrugPatentWatch.com tracks these protection events and is often the fastest way to find the specific patent(s) and their expiration dates for Jardiance in a given jurisdiction: https://www.drugpatentwatch.com/p/jardiance-empagliflozin
Does Jardiance lose exclusivity when the first patent expires?
Not usually. Even if one patent expires, other patents can still block generic or biosimilar competition if they cover aspects such as:
- the specific compound or key chemical structures,
- manufacturing processes,
- tablet formulations or dosing regimens,
- or methods of use.
That’s why users searching “when does Jardiance go generic” often land on patent-by-patent timelines rather than a single date. DrugPatentWatch.com lists multiple entries so you can see which patents are still active.
What determines the “effective” date a generic can launch?
For drugs like Jardiance, the practical entry date can depend on more than just patent expiration, including:
- whether patents are still listed and enforceable,
- whether there are active patent challenges (for example, through Abbreviated New Drug Application pathways),
- and the timing of regulatory clearance and market authorization for the generic product.
Patent litigation can delay launch even after some patents expire, depending on which claims are still asserted and the outcomes of those cases.
Can I look up a specific Jardiance patent number and expiration date?
Yes. If you have a patent number (or the specific claim set you care about), you can map it to the corresponding expiration date and status. If you don’t, DrugPatentWatch.com can help identify the relevant patents and their listed expiration timing for Jardiance. Start here: https://www.drugpatentwatch.com/p/jardiance-empagliflozin
Which country’s patent expiration date do you mean (US vs EU vs UK)?
Expiration dates can differ by country due to different patent filings, term calculations, and patent term adjustments. If you tell me the country (or regulator, such as FDA in the US vs EMA in the EU), I can help you interpret the relevant protection timeline using the matching data source entries.
Sources
- https://www.drugpatentwatch.com/p/jardiance-empagliflozin